Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Female infertility associated with anovulation |
French
|
Stérilité associée à une anovulation |
| Level | Code | Title | |
|---|---|---|---|
| 1 | XIV | Diseases of the genitourinary system | |
| 2 | N80-N98 | Noninflammatory disorders of female genital tract | |
| 3 | N97 | Female infertility | |
| 4 | N97.0 | Female infertility associated with anovulation |
| Active Ingredient | Description | |
|---|---|---|
| Choriogonadotropin alpha |
The principal pharmacodynamic activity in women is oocyte meiosis resumption, follicular rupture (ovulation), corpus luteum formation and production of progesterone and estradiol by the corpus luteum. |
|
| Follitropin alfa |
In women, the most important effect resulting from parenteral administration of FSH is the development of mature Graafian follicles. |
|
| Follitropin beta |
Follitropin beta is a recombinant FSH. Follitropin beta can be used to stimulate follicular development and steroid production in selected cases of disturbed gonadal function. Furthermore follitropin beta can be used to promote multiple follicular development in medically assisted reproduction programs. |
|
| Urofollitropin |
Urofollitropin contains a highly purified preparation of urinary FSH extracted from the urine of postmenopausal women. FSH stimulates ovarian follicular growth and development as well as gonadal steroid production in women who do not have primary ovarian failure. |
